)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
The subscription-based Elite Buyer Program gives users category-specific tags and verified leads to speed up responses and boost trust in second-hand transactions
SAVWIPL becomes Bentley's exclusive importer and distributor in India from July 2025, establishing Bentley India and expanding its luxury portfolio in the country
Passenger vehicle makers are offering deep discounts to clear unsold 2024 stock, while two-wheeler companies stay cautious amid steady demand and manageable inventories
Sun Pharma expects global pricing strain due to policy shifts, as FY25 US sales rise 5.8% despite compliance challenges; specialty business lifts overall growth
BE 6 and XEV 9e Pack Two models to feature a new 79 kWh battery option with a 500 km range, Level 2 ADAS, fast charging and expanded connected car features
The chief minister said the government was probing if Covid vaccines -- which were "hastily approved" during the pandemic -- could be among the reasons behind these incidents
Creta records 15,786 units in June 2025, just ahead of Dzire, and ranks second in H1 sales as SUV demand remains strong amid competition from Maruti's broad lineup
In June, overall industry volumes dipped. According to industry estimates, wholesales fell 6.4 per cent to 320,000 units
ICRA projects modest 3-5 per cent growth for CV sector in FY26 on infrastructure revival, with buses outpacing other segments at 8-10 per cent growth
Anish Shah and Rajesh Jejurikar received pay hikes of up to 98 per cent in FY25 as Mahindra Group delivered strong growth in its automobile and farm sectors
Shift is expected to drive a sharp increase in generic drug launches, positioning Indian drugmakers for strong growth
Mahindra likens global flux to Samudra Manthan and urges Indian industry to embrace innovation, invest in manufacturing, and act swiftly to capture supply chain realignment
With 18 per cent CAGR, India's genomic diagnostics market is expanding into Tier 2 and 3 cities as affordability, cancer screening, and personalised care fuel adoption
Experts believe that the drug still holds potential for future market entry, and the current development should be viewed as a temporary setback
Aiming for global equity, Bharat Biotech and GSK will reduce the RTS,S vaccine price by over 50 per cent by 2028 through expanded production and tech transfer
Wegovy enters the Indian market as the first GLP-1 drug approved for both weight loss and cardiovascular risk reduction, competing with Eli Lilly's Mounjaro
The company currently produces around 25 crore units a month and is expanding its ground and first-floor production facilities to meet rising demand
Mahajan Labs data from over 4,000 CT scans in 2024 reveals high incidence of early-stage lung abnormalities in Delhi youth, likely tied to pollution and lifestyle
Sub-125cc segment is 29% of motorcycle sales, 18% of two-wheeler volumes
ICRA warns that rare-earth magnet inventories for EV motors may run dry by mid-July as China tightens export rules, leaving Indian auto makers facing serious supply disruption